Cheaper drug may match expensive biologic in artery disease
NCT ID NCT03892785
First seen Nov 26, 2025 · Last updated May 01, 2026 · Updated 15 times
Summary
This study compares two treatments—methotrexate and tocilizumab—for giant cell arteritis, a disease that causes inflammation in large arteries. About 230 adults over 50 will receive one of the drugs for 12 months to see which better prevents relapses while reducing steroid use. The goal is to find a safer, more affordable option for long-term disease control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Dijon
Dijon, 21079, France
Conditions
Explore the condition pages connected to this study.